| Vol. 15.04 – 2 February, 2023 |
| |
|
|
| Researchers evaluated the efficacy and explored molecular mechanisms of human umbilical cord MSCs (hucMSCs) and hucMSC-derived exosomes on diabetes- and obesity-induced muscle atrophy. [Journal Of Cachexia Sarcopenia And Muscle] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors investigated the feasibility of constructing a small vascular graft from decellularized amniotic membranes (DAMs). The genipin-crosslinked DAM graft showed an improved integrated structure, prolonged stability, proper mechanical property, and superior biocompatibility. [Biofabrication] |
|
|
|
| Researchers selected an appropriate cytokine, IL-18, based on the special cytokine expression profile in severe pneumonia of mice induced by H1N1 virus to prime human umbilical cord-MSCs in vitro and improved the therapeutic effect of hUC-MSCs in vivo. [Cell Death & Disease] |
|
|
|
| The effect of exosomes derived from human amniotic MSCs on diabetic wound healing were tested by measuring wound closure rates and immunohistochemical staining of CD31. [Tissue Engineering And Regenerative Medicine] |
|
|
|
| Scientists demonstrated that protein O-fucosyltransferase 1 (poFUT1) promoted the proliferation, migration ability, and angiogenesis potential of trophoblast cells. [Biology of Reproduction] |
|
|
|
| Investigators evaluated the impact of human umbilical cord blood-derived MSC transplantation on long-term outcomes in patients with decompensated liver cirrhosis. [Journal of Gastrointestinal Surgery] |
|
|
|
|
| The authors summarize evidence regarding the effects of human umbilical cord MSCs on esophageal cancer with a mechanistic insight. [Cell Biology International] |
|
|
|
|
| A panel of experts joined a meeting of the US National Science Advisory Board of Biosecurity, discussing on issues such as how privately funded risky research would be regulated, the role of research institutions in identifying potentially dangerous research, and much more. [Nature] |
|
|
|
|
| April 17 – 19, 2023 Freiburg im Breisgau, Germany |
|
|
|
|
|
| Fred Hutchinson Cancer Center – Seattle, Washington, United States |
|
|
|
| University of Florida – Gainesville, Florida, United States |
|
|
|
| Medical College of Wisconsin – Milwaukee, Wisconsin, United States |
|
|
|
| The Ottawa Hospital – Ottawa, Ontario, Canada |
|
|
|
|
MRC National Institute for Medical Research – Cambridge, England, United Kingdom |
| | | | | | | | | |
|
|